165 related articles for article (PubMed ID: 24336595)
1. [The PRATO-ACS study].
Marenzi G; Briguori C
G Ital Cardiol (Rome); 2013 Dec; 14(12):803-8. PubMed ID: 24336595
[No Abstract] [Full Text] [Related]
2. Impact of high-dose statin pre-treatment and contrast-induced acute kidney injury on follow-up events in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
Patti G; Leoncini M; Toso A; Maioli M; Grieco D; Colonna G; Bellandi F; Di Sciascio G
Int J Cardiol; 2014 Jun; 174(2):440-1. PubMed ID: 24767765
[No Abstract] [Full Text] [Related]
3. Statins for the prevention of contrast-induced acute kidney injury.
Ball T; McCullough PA
Nephron Clin Pract; 2014; 127(1-4):165-71. PubMed ID: 25343843
[TBL] [Abstract][Full Text] [Related]
4. Impact of Rosuvastatin on contrast-induced acute kidney injury in patients at high risk for nephropathy undergoing elective angiography.
Abaci O; Arat Ozkan A; Kocas C; Cetinkal G; Sukru Karaca O; Baydar O; Kaya A; Gurmen T
Am J Cardiol; 2015 Apr; 115(7):867-71. PubMed ID: 25670636
[TBL] [Abstract][Full Text] [Related]
5. Statin, the black box.
Hatem S; Boccara F
Arch Cardiovasc Dis; 2008 Jun; 101(6):377-9. PubMed ID: 18809149
[No Abstract] [Full Text] [Related]
6. Early high-dose rosuvastatin and cardioprotection in the protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome (PRATO-ACS) study.
Leoncini M; Toso A; Maioli M; Tropeano F; Badia T; Villani S; Bellandi F
Am Heart J; 2014 Nov; 168(5):792-7. PubMed ID: 25440809
[TBL] [Abstract][Full Text] [Related]
7. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
[TBL] [Abstract][Full Text] [Related]
8. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
[TBL] [Abstract][Full Text] [Related]
9. The Jupiter trial--new territory for statins?
Wheeler DC
Nephrol Dial Transplant; 2009 Jul; 24(7):2036-7. PubMed ID: 19541666
[No Abstract] [Full Text] [Related]
10. [The JUPITER study].
Gaspardone A; Maseri A
G Ital Cardiol (Rome); 2009 May; 10(5):267-70. PubMed ID: 19537439
[No Abstract] [Full Text] [Related]
11. CORONA--rosuvastatin in older patients with systolic heart failure.
Jackson G
Int J Clin Pract; 2008 Jan; 62(1):1. PubMed ID: 18173807
[No Abstract] [Full Text] [Related]
12. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
Serebruany VL
Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
[No Abstract] [Full Text] [Related]
13. Preventive effects of rosuvastatin on atrial fibrillation: a meta-analysis of randomized controlled trials.
Liu T; Korantzopoulos P; Li L; Li G
Int J Cardiol; 2013 Sep; 167(6):3058-60. PubMed ID: 23194786
[No Abstract] [Full Text] [Related]
14. The cost-effectiveness of rosuvastatin therapy JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Hlatky M
J Am Coll Cardiol; 2011 Feb; 57(7):792-3. PubMed ID: 21310314
[No Abstract] [Full Text] [Related]
15. [The GISSI-HF trial].
Tavazzi L; Nodari S
G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
[No Abstract] [Full Text] [Related]
16. Rosuvastatin in patients with elevated C-reactive protein.
Pierard LA
N Engl J Med; 2009 Mar; 360(10):1040; author reply 1041-2. PubMed ID: 19271277
[No Abstract] [Full Text] [Related]
17. Rosuvastatin Treatment for Preventing Contrast-Induced Acute Kidney Injury After Cardiac Catheterization: A Meta-Analysis of Randomized Controlled Trials.
Yang Y; Wu YX; Hu YZ
Medicine (Baltimore); 2015 Jul; 94(30):e1226. PubMed ID: 26222855
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin calcium in acute coronary syndromes.
Aggarwal RK; Showkathali R
Expert Opin Pharmacother; 2013 Jun; 14(9):1215-27. PubMed ID: 23574635
[TBL] [Abstract][Full Text] [Related]
19. A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein.
Takagi H; Umemoto T
Int J Cardiol; 2012 Jan; 154(1):78-81. PubMed ID: 22019059
[No Abstract] [Full Text] [Related]
20. CORONA, statins, and heart failure: who lost the crown?
Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
[No Abstract] [Full Text] [Related]
[Next] [New Search]